CH404656A - Verfahren zur Herstellung von 1-Methyl-17a-alkyl- 1-androsten-17B-ol-3-onen - Google Patents
Verfahren zur Herstellung von 1-Methyl-17a-alkyl- 1-androsten-17B-ol-3-onenInfo
- Publication number
- CH404656A CH404656A CH604265A CH604265A CH404656A CH 404656 A CH404656 A CH 404656A CH 604265 A CH604265 A CH 604265A CH 604265 A CH604265 A CH 604265A CH 404656 A CH404656 A CH 404656A
- Authority
- CH
- Switzerland
- Prior art keywords
- androsten
- ones
- alkyl
- methyl
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DESCH27090A DE1117113B (de) | 1959-12-05 | 1959-12-05 | Verfahren zur Herstellung ª‡ú¼ ª‰-ungesaettigter Ketosteroide, die am ª‰-staendigen Kohlenstoffatom eine Methylgruppe tragen |
DESCH27300A DE1117573B (de) | 1960-01-20 | 1960-01-20 | Verfahren zur Herstellung von 1-Methyl-17ª‡-alkyl-í¸-androsten-17ª‰-ol-3-onen |
DESCH27643A DE1122947B (de) | 1960-03-26 | 1960-03-26 | Verfahren zur Herstellung anabolisch wirksamer Carbonsaeureester des 1-Methyl-í¸-androsten-17ª‰-ol-3-ons |
Publications (1)
Publication Number | Publication Date |
---|---|
CH404656A true CH404656A (de) | 1965-12-31 |
Family
ID=27212270
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH1237560A CH403750A (de) | 1959-12-05 | 1960-11-04 | Verfahren zur Herstellung von a,B-ungesättigten Ketosteroiden, die am B-ständigen Kohlenstoffatom eine Methylgruppe tragen |
CH604265A CH404656A (de) | 1959-12-05 | 1960-11-04 | Verfahren zur Herstellung von 1-Methyl-17a-alkyl- 1-androsten-17B-ol-3-onen |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH1237560A CH403750A (de) | 1959-12-05 | 1960-11-04 | Verfahren zur Herstellung von a,B-ungesättigten Ketosteroiden, die am B-ständigen Kohlenstoffatom eine Methylgruppe tragen |
Country Status (3)
Country | Link |
---|---|
BE (1) | BE597814A (de) |
CH (2) | CH403750A (de) |
GB (1) | GB965090A (de) |
-
1960
- 1960-11-04 CH CH1237560A patent/CH403750A/de unknown
- 1960-11-04 CH CH604265A patent/CH404656A/de unknown
- 1960-11-11 GB GB3887160A patent/GB965090A/en not_active Expired
- 1960-12-05 BE BE597814A patent/BE597814A/fr unknown
Also Published As
Publication number | Publication date |
---|---|
GB965090A (en) | 1964-07-29 |
CH403750A (de) | 1965-12-15 |
BE597814A (fr) | 1961-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CH370197A (de) | Verfahren zur Herstellung von Actinospectacin | |
CH387047A (de) | Verfahren zur Herstellung von Ketosidopurinen | |
CH400144A (de) | Verfahren zur Herstellung von 16-Methylen-17a-hydroxy-progesteron-17-acylaten | |
CH419127A (de) | Verfahren zur Herstellung von substituierten 3-Pyrrolidinolen | |
CH404962A (de) | Verfahren zur Herstellung von Eupolyoxymethylenen | |
CH396026A (de) | Verfahren zur Herstellung von Halogenalkylaminen | |
CH387606A (de) | Verfahren zur Herstellung von Tetrahydroxydibor | |
CH399742A (de) | Verfahren zur Herstellung von Eupolyoxymethylenen | |
CH440249A (de) | Verfahren zur Herstellung von Polychlorbenzonitrilen | |
CH387029A (de) | Verfahren zur Herstellung von 9a-Fluor-11B-oxy-16a-methylprogesteron | |
CH380730A (de) | Verfahren zur Herstellung von 4-Methoxy-2-methyl-6-sulfanilamidopyrimidin | |
CH417595A (de) | Verfahren zur Herstellung von Alkyl-5-alkylisoxazol-3-carboxylaten | |
CH416113A (de) | Verfahren zur Herstellung von Eupolyoxymethylenen | |
CH538458A (de) | Verfahren zur Herstellung von a-Dithiosemicarbazonen | |
CH372297A (de) | Verfahren zur Herstellung von 4-2-tert.-Aminomethyl-3-keto-steroiden | |
CH387048A (de) | Verfahren zur Herstellung von 7-Theophyllinderivaten | |
CH378344A (de) | Verfahren zur Herstellung von 2-Amino-anthrachinonen | |
CH412841A (de) | Verfahren zur Herstellung von 2-Trifluormethylbenzophenon | |
AT241484B (de) | Verfahren zur Herstellung von Glucofuranosiden | |
AT221103B (de) | Verfahren zur Herstellung von Monoalkylphosphinen | |
AT217458B (de) | Verfahren zur Herstellung von Chlorbenzonitrilen | |
AT221096B (de) | Verfahren zur Herstellung von 2-Hydrazino-3-mercapto-chinoxalin | |
AT221494B (de) | Verfahren zur Herstellung von α-Amino-ω-lactamen | |
CH404672A (de) | Verfahren zur Herstellung von 9-D-Psicofuranosylpurin | |
CH473794A (de) | Verfahren zur Herstellung von 6-Fluorsteroiden |